Acelyrin (Acelyrin) Price-to-Tangible-Book : 0.71 (As of May. 16, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Acelyrin Price-to-Tangible-Book?

As of today (2024-05-16), Acelyrin's share price is $4.63. Acelyrin's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $6.52. Hence, Acelyrin's Price to Tangible Book Ratio of today is 0.71.

The historical rank and industry rank for Acelyrin's Price-to-Tangible-Book or its related term are showing as below:

SLRN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.71 Med: 1.23 Max: 2.54
Current: 0.71

During the past 3 years, Acelyrin's highest Price to Tangible Book Ratio was 2.54. The lowest was 0.71. And the median was 1.23.

SLRN's Price-to-Tangible-Book is ranked better than
89.44% of 1231 companies
in the Biotechnology industry
Industry Median: 2.81 vs SLRN: 0.71

A closely related ratio is called PB Ratio. As of today, Acelyrin's share price is $4.63. Acelyrin's Book Value per Sharefor the quarter that ended in Mar. 2024 was $6.52. Hence, Acelyrin's P/B Ratio of today is 0.71.

Acelyrin Price-to-Tangible-Book Historical Data

The historical data trend for Acelyrin's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acelyrin Price-to-Tangible-Book Chart

Acelyrin Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

1.11

Acelyrin Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial					-	2.54	1.35	1.11	1.04

Competitive Comparison of Acelyrin's Price-to-Tangible-Book

For the Biotechnology subindustry, Acelyrin's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acelyrin's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acelyrin's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Acelyrin's Price-to-Tangible-Book falls into.

Acelyrin Price-to-Tangible-Book Calculation

Acelyrin's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	4.63	/	6.515
	=	0.71

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Acelyrin Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Acelyrin's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Acelyrin (Acelyrin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acelyrin Inc (NAS:SLRN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

4149 Liberty Canyon Road, Agoura Hills, CA, USA, 91301

Website

https://www.acelyrin.com

Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates.

Executives

Shao-lee Lin	director, officer: Chief Executive Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Gil M Labrucherie	officer: Interim CFO	150 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Beth C Seidenberg	director, 10 percent owner
Henry O Gosebruch	director	1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064-6092
Mardi Dier	officer: CFO and CBO	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Mina Kim	officer: Chief Legal & Admin. Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Ronald Oyston	officer: Chief People Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON ROAD, AGOURA HILLS CA 91301
Paul Peloso	officer: Chief Medical Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON ROAD, AGOURA HILLS CA 91301
Dawn Svoronos	director	C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105
Daniel J. Becker	director	C/O NEW LEAF VENTURE PARTNERS, TIMES SQ TOWER, 7 TIMES SQ, STE 3502, NEW YORK NY 10036
Westlake Biopartners Fund Ii, L.p.	10 percent owner	3075 TOWNSGATE ROAD, SUITE 140, WESTLAKE VILLAGE CA 91361
Ayurmaya Capital Management Company, Lp	director, 10 percent owner, other: See Remarks	1000 WINTER STREET, SUITE 4500, WALTHAM MA 02451
Sean E Harper	10 percent owner	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Melanie Gloria	officer: Chief Operating Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON ROAD, AGOURA HILLS CA 91301
Westlake Biopartners Gp Ii, Llc	10 percent owner	3075 TOWNSGATE ROAD, SUITE 140, WESTLAKE VILLAGE CA 91361